Market Overview:
The global zolmitriptan nasal spray market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of migraine, rising awareness about zolmitriptan nasal spray and its benefits, and the launch of new products. Based on type, the global zolmitriptan nasal spray market can be segmented into adult and children. The adult segment is expected to account for a larger share of the market in 2018. This segment is projected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. Based on application, the global zolmitriptan nasal spray market can be divided into hospital, clinic, and others segments.
Product Definition:
Zolmitriptan nasal spray is a medication used to treat migraine headaches. It is a serotonin receptor agonist that works by narrowing the blood vessels in the brain, which helps to relieve the headache pain. Zolmitriptan nasal spray is important because it can be used to quickly relieve migraine symptoms, and it has fewer side effects than some other medications for migraines.
Adult:
Zolmitriptan is a non-narcotic, non-addictive, and FDA approved drug for the treatment of migraine. It’s mechanism of action is by binding to serotonin receptors in the brain which causes an analgesic effect. The drug has been found to be effective in reducing both chronic and acute pain as well as prevent new attacks by acting as a preventive medication.
Children:
Zolmitriptan is a nasal spray used for the treatment of migraine. It is also used as an off-label drug for treating cluster headaches, which are more frequent and severe than migraines. The active ingredient in zolmitriptan, sumatRIPTAN (asmritinib), was patented by AsmoCo Pharmaceuticals in 2005 and received FDA approval in 2007.
Application Insights:
The others application segment held the largest share of over 69.0% in 2017. The other applications include home care, urgent care center and others. Homecare was the largest revenue generating segment for zolmitriptan nasal spray in 2017 owing to increasing awareness about migraine among general population, growing preference for self-diagnosis and growing prevalence of migraine among adults in developed countries including U.S.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high awareness levels regarding migraine, presence of well-established healthcare facilities and availability of highly skilled doctors. In addition, favorable reimbursement policies for patients are also expected to drive the regional demand over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast years due to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Growing consumer awareness regarding treatment options available for chronic pain disorders is further anticipated boost product demand during the projected time frame. For instance, zolmitriptan was recently launched by Merck & Co., Inc.; however; Sun Pharmaceutical Industries Ltd.; has a license agreement with GlaxoSmithKline plc for commercialization of Zomig tablets in India since 2016 under brand name ‘Zomig two-a-day’ (tritace).
Growth Factors:
- Increasing prevalence of migraine and other headache disorders
- Growing awareness about the benefits of Zolmitriptan nasal spray over oral medications
- Rising demand for fast-acting and long-lasting medications for the treatment of migraine headaches
- Availability of Zolmitriptan nasal spray in a convenient pre-filled dispenser format
- Launch of new products by key players to capture larger market share
Scope Of The Report
Report Attributes
Report Details
Report Title
Zolmitriptan Nasal Spray Market Research Report
By Type
Adult, Children
By Application
Hospital, Clinic, Others
By Companies
Pfizer, Bayer, AptarGroup, Merck, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Zolmitriptan Nasal Spray Market Report Segments:
The global Zolmitriptan Nasal Spray market is segmented on the basis of:
Types
Adult, Children
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Bayer
- AptarGroup
- Merck
- Sanofi
Highlights of The Zolmitriptan Nasal Spray Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adult
- Children
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zolmitriptan Nasal Spray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zolmitriptan nasal spray is a medication used to relieve migraine headaches. It is a pill that you take by mouth. Zolmitriptan nasal spray works by blocking pain signals from your brain to your head.
Some of the major companies in the zolmitriptan nasal spray market are Pfizer, Bayer, AptarGroup, Merck, Sanofi.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Zolmitriptan Nasal Spray Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Zolmitriptan Nasal Spray Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Zolmitriptan Nasal Spray Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Zolmitriptan Nasal Spray Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Zolmitriptan Nasal Spray Market Size & Forecast, 2018-2028
4.5.1 Zolmitriptan Nasal Spray Market Size and Y-o-Y Growth
4.5.2 Zolmitriptan Nasal Spray Market Absolute $ Opportunity
Chapter 5 Global Zolmitriptan Nasal Spray Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Zolmitriptan Nasal Spray Market Size Forecast by Type
5.2.1 Adult
5.2.2 Children
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Zolmitriptan Nasal Spray Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Zolmitriptan Nasal Spray Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Zolmitriptan Nasal Spray Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Zolmitriptan Nasal Spray Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Zolmitriptan Nasal Spray Analysis and Forecast
9.1 Introduction
9.2 North America Zolmitriptan Nasal Spray Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Zolmitriptan Nasal Spray Market Size Forecast by Type
9.6.1 Adult
9.6.2 Children
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Zolmitriptan Nasal Spray Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Zolmitriptan Nasal Spray Analysis and Forecast
10.1 Introduction
10.2 Europe Zolmitriptan Nasal Spray Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Zolmitriptan Nasal Spray Market Size Forecast by Type
10.6.1 Adult
10.6.2 Children
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Zolmitriptan Nasal Spray Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Zolmitriptan Nasal Spray Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Zolmitriptan Nasal Spray Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Zolmitriptan Nasal Spray Market Size Forecast by Type
11.6.1 Adult
11.6.2 Children
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Zolmitriptan Nasal Spray Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Zolmitriptan Nasal Spray Analysis and Forecast
12.1 Introduction
12.2 Latin America Zolmitriptan Nasal Spray Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Zolmitriptan Nasal Spray Market Size Forecast by Type
12.6.1 Adult
12.6.2 Children
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Zolmitriptan Nasal Spray Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Zolmitriptan Nasal Spray Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Zolmitriptan Nasal Spray Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Zolmitriptan Nasal Spray Market Size Forecast by Type
13.6.1 Adult
13.6.2 Children
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Zolmitriptan Nasal Spray Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Zolmitriptan Nasal Spray Market: Competitive Dashboard
14.2 Global Zolmitriptan Nasal Spray Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Bayer
14.3.3 AptarGroup
14.3.4 Merck
14.3.5 Sanofi
